Literature DB >> 34697026

Anti-ANP32A antibodies in systemic sclerosis.

Rachel Wallwork1, Livia Casciola-Rosen1, Ami A Shah2.   

Abstract

Entities:  

Keywords:  autoantibodies; autoimmune diseases; scleroderma; systemic

Mesh：

Substances：

Year:  2021        PMID： 34697026      PMCID： PMC8961456          DOI： 10.1136/annrheumdis-2021-221354

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

Authors:  Ami A Shah; Antony Rosen; Laura Hummers; Fredrick Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

3.  Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.

Authors:  Takeru Igusa; Laura K Hummers; Kala Visvanathan; Carrie Richardson; Fredrick M Wigley; Livia Casciola-Rosen; Antony Rosen; Ami A Shah
Journal:  Ann Rheum Dis       Date:  2018-04-20       Impact factor: 19.103

4.  The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.

Authors:  David Fiorentino; Lorinda Chung; Jeff Zwerner; Antony Rosen; Livia Casciola-Rosen
Journal:  J Am Acad Dermatol       Date:  2011-04-29       Impact factor: 11.527

5.  Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.

Authors:  Christopher A Mecoli; Brittany L Adler; Qingyuan Yang; Laura K Hummers; Antony Rosen; Livia Casciola-Rosen; Ami A Shah
Journal:  Arthritis Rheumatol       Date:  2020-12-26       Impact factor: 10.995
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.